Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? SciClone Pharmaceuticals, Inc.
SciClone Pharmaceuticals shares declined 8.7 percent on nearly three times the average daily volume Monday to close at $4.40 a share. The company announced it would restate financial statements for the first, second and third quarters of 2012 and the second and third quarters of 2011 and for the year ended December 31, 2011.
Going forward ... (see research report)
Subscribe to News Feeds